Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Adenocarcinoma 1

Interventions

aldesleukin 2Specimen Handling 2Radiosurgery 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Cetuximab 2Biopsy 2Bevacizumab 2vactosertib 1titanium silicide 1regorafenib 1fludarabine phosphate 1encorafenib 1apatinib 1S 1 (combination) 1Riluzole 1Radiotherapy 1Nivolumab 1Maintenance 1Leucovorin 1Irinotecan 1Interviews as Topic 1Immunotherapy 1IL32 protein, human 1Hepatectomy 1Focus Groups 1Fluorouracil 1Flavonoids 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Colorectal Neoplasms × Anticoagulants × Clear all
NCT00443573 2008-05-07

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

ARCA Biopharma, Inc.

Phase 1/2 Suspended
100 enrolled
Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡